Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 9:44 AM UTC
| NCT Number | NCT06376526 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dickran Kazandjian, MD |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 3, 2026: Clinical trial NCT06376526 is currently recruiting participants. This phase2 study for multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Dickran Kazandjian, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06376526 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06376526 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.